CY4GATE SPA (CY4.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:CY4 • IT0005412504

7.085 EUR
-0.17 (-2.41%)
Last: Feb 4, 2026, 02:15 PM
Fundamental Rating

3

Overall CY4 gets a fundamental rating of 3 out of 10. We evaluated CY4 against 115 industry peers in the Software industry. CY4 has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, CY4 is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CY4 has reported negative net income.
  • CY4 had a positive operating cash flow in the past year.
  • In multiple years CY4 reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CY4 reported negative operating cash flow in multiple years.
CY4.MI Yearly Net Income VS EBIT VS OCF VS FCFCY4.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • CY4's Return On Assets of -9.06% is on the low side compared to the rest of the industry. CY4 is outperformed by 79.13% of its industry peers.
  • CY4's Return On Equity of -18.20% is on the low side compared to the rest of the industry. CY4 is outperformed by 74.78% of its industry peers.
Industry RankSector Rank
ROA -9.06%
ROE -18.2%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CY4.MI Yearly ROA, ROE, ROICCY4.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

  • With a Gross Margin value of 43.51%, CY4 is not doing good in the industry: 73.04% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of CY4 has remained more or less at the same level.
  • CY4 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
CY4.MI Yearly Profit, Operating, Gross MarginsCY4.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

3

2. Health

2.1 Basic Checks

  • CY4 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for CY4. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CY4.MI Yearly Shares OutstandingCY4.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
CY4.MI Yearly Total Debt VS Total AssetsCY4.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of 1.40, we must say that CY4 is in the distress zone and has some risk of bankruptcy.
  • CY4's Altman-Z score of 1.40 is on the low side compared to the rest of the industry. CY4 is outperformed by 66.09% of its industry peers.
  • CY4 has a debt to FCF ratio of 3.47. This is a good value and a sign of high solvency as CY4 would need 3.47 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 3.47, CY4 perfoms like the industry average, outperforming 54.78% of the companies in the same industry.
  • CY4 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of CY4 (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 3.47
Altman-Z 1.4
ROIC/WACCN/A
WACC9.17%
CY4.MI Yearly LT Debt VS Equity VS FCFCY4.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that CY4 should not have too much problems paying its short term obligations.
  • CY4 has a Current ratio of 1.32. This is comparable to the rest of the industry: CY4 outperforms 44.35% of its industry peers.
  • CY4 has a Quick Ratio of 1.29. This is a normal value and indicates that CY4 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CY4 (1.29) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.29
CY4.MI Yearly Current Assets VS Current LiabilitesCY4.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

  • CY4 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.22%, which is quite impressive.
  • Looking at the last year, CY4 shows a very strong growth in Revenue. The Revenue has grown by 28.46%.
  • Measured over the past years, CY4 shows a very strong growth in Revenue. The Revenue has been growing by 59.24% on average per year.
EPS 1Y (TTM)41.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.13%
Revenue 1Y (TTM)28.46%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%32.24%

3.2 Future

  • CY4 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.72% yearly.
  • The Revenue is expected to grow by 9.12% on average over the next years. This is quite good.
EPS Next Y29.66%
EPS Next 2Y42.34%
EPS Next 3Y33.72%
EPS Next 5YN/A
Revenue Next Year15.13%
Revenue Next 2Y10.38%
Revenue Next 3Y9.12%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CY4.MI Yearly Revenue VS EstimatesCY4.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
CY4.MI Yearly EPS VS EstimatesCY4.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

  • CY4 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 1079.21 indicates a quite expensive valuation of CY4.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CY4 indicates a slightly more expensive valuation: CY4 is more expensive than 69.57% of the companies listed in the same industry.
  • CY4 is valuated expensively when we compare the Price/Forward Earnings ratio to 25.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1079.21
CY4.MI Price Earnings VS Forward Price EarningsCY4.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CY4 is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
  • Based on the Price/Free Cash Flow ratio, CY4 is valued cheaply inside the industry as 81.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.73
EV/EBITDA 48.35
CY4.MI Per share dataCY4.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CY4 does not grow enough to justify the current Price/Earnings ratio.
  • CY4's earnings are expected to grow with 33.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.34%
EPS Next 3Y33.72%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for CY4!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CY4GATE SPA

BIT:CY4 (2/4/2026, 2:15:35 PM)

7.085

-0.17 (-2.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners13.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap166.99M
Revenue(TTM)113.27M
Net Income(TTM)-16.38M
Analysts86.67
Price Target8.31 (17.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP2.35%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.4%
PT rev (3m)34.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)14.6%
EPS NY rev (3m)19.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1079.21
P/S 1.47
P/FCF 14.73
P/OCF 12.37
P/B 1.86
P/tB 12.91
EV/EBITDA 48.35
EPS(TTM)-0.66
EYN/A
EPS(NY)0.01
Fwd EY0.09%
FCF(TTM)0.48
FCFY6.79%
OCF(TTM)0.57
OCFY8.08%
SpS4.81
BVpS3.82
TBVpS0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.06%
ROE -18.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.51%
FCFM 10.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y-0.54%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 3.47
Debt/EBITDA 5.15
Cap/Depr 9.94%
Cap/Sales 1.91%
Interest Coverage N/A
Cash Conversion 330.53%
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 1.29
Altman-Z 1.4
F-Score5
WACC9.17%
ROIC/WACCN/A
Cap/Depr(3y)19.8%
Cap/Depr(5y)17.04%
Cap/Sales(3y)4.99%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.13%
EPS Next Y29.66%
EPS Next 2Y42.34%
EPS Next 3Y33.72%
EPS Next 5YN/A
Revenue 1Y (TTM)28.46%
Revenue growth 3Y61.94%
Revenue growth 5Y59.24%
Sales Q2Q%32.24%
Revenue Next Year15.13%
Revenue Next 2Y10.38%
Revenue Next 3Y9.12%
Revenue Next 5YN/A
EBIT growth 1Y16.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2883.33%
EBIT Next 3Y245.52%
EBIT Next 5YN/A
FCF growth 1Y57.74%
FCF growth 3YN/A
FCF growth 5Y87.64%
OCF growth 1Y25.87%
OCF growth 3YN/A
OCF growth 5Y43.36%

CY4GATE SPA / CY4.MI FAQ

Can you provide the ChartMill fundamental rating for CY4GATE SPA?

ChartMill assigns a fundamental rating of 3 / 10 to CY4.MI.


What is the valuation status for CY4 stock?

ChartMill assigns a valuation rating of 2 / 10 to CY4GATE SPA (CY4.MI). This can be considered as Overvalued.


Can you provide the profitability details for CY4GATE SPA?

CY4GATE SPA (CY4.MI) has a profitability rating of 1 / 10.


What is the expected EPS growth for CY4GATE SPA (CY4.MI) stock?

The Earnings per Share (EPS) of CY4GATE SPA (CY4.MI) is expected to grow by 29.66% in the next year.